Waddell & Reed Financial’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
NAMA
MCMC
GGHC
Waddell & Reed Financial's VCYT Position: Q1 2021 in Review
Waddell & Reed Financial reduced its Veracyte (VCYT) stake by 50% in Q1 2021, selling an estimated $30.4M and leaving 518,499 shares worth $27.9M. The position accounts for 0.06% of the portfolio, ranked #324.
Waddell & Reed Financial first reported a position in VCYT in Q3 2019 and has held it in 7 quarters since. The position peaked at $51.2M in Q4 2020. 235 funds tracked by Wall St. Rank hold VCYT as of Q1 2021.
- Waddell & Reed Financial held 518,499 shares of Veracyte worth $27.9M as of Q1 2021.
- Waddell & Reed Financial sold 527,371 Veracyte shares in Q1 2021, an estimated $30.4M.
- Veracyte made up 0.06% of Waddell & Reed Financial's portfolio in Q1 2021, its #324 holding.
- Waddell & Reed Financial first reported a position in Veracyte in Q3 2019 and has held it in 7 quarters since.
- Waddell & Reed Financial's Veracyte position peaked at $51.2M in Q4 2020.
- 235 funds tracked by Wall St. Rank held Veracyte as of Q1 2021.
Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.